High density lipoprotein metabolism
|
|
- Meagan Matthews
- 5 years ago
- Views:
Transcription
1 High density lipoprotein metabolism
2 Lipoprotein classes and atherosclerosis Chylomicrons, VLDL, and their catabolic remnants Pro-atherogenic LDL HDL Anti-atherogenic
3 Plasma lipid transport Liver VLDL FC FC TG FFA TG LPL LDL FFA Adipose and other tissues Adipose tissue TP TG Liver LDL receptor LDL receptor Bile HDL TG LCAT ABCA1 FC New synthesis Cell in peripheral tissue
4 HDL and cardiovascular disease
5 Hazard Ratio Coronary heart disease and HDL-C N = 302,430 Adjusted for age and gender Adjusted for multiple factors HDL-C (mmol/l) The Emerging Risk Factors Collaboration. JAMA 2009;302:
6 What are HDLs?
7 Structure of HDL Surface monolayer of phospholipids and free cholesterol apoa-i apoa-ii Hydrophobic core of triglyceride and cholesteryl esters
8 HDL are heterogeneous COMPOSITION APOLIPOPROTEINS ApoA-I, apoa-ii, apoa-iv, apoe, others LIPIDS TG,, FC, PL SIZE: nm SHAPE: spherical, discoidal CHARGE: prebeta, alpha
9 HDL Charge and shape Lipid-poor apoa-i Prebeta mobility Discoidal Prebeta mobility Spherical Alpha mobility
10 HDL Subpopulations PARTICLE SHAPE APOLIPOPROTEIN COMPOSITION Discoidal Spherical A-I HDL A-I/A-II HDL PARTICLE SIZE Lipid-poor apoa-i HDL 2b HDL 2a HDL 3a HDL 3b HDL 3c
11 This HDL heterogeneity is the result of activity of several factors that assemble and remodel HDL in plasma
12 Origin of apoa-i LIVER INTESTINE Chylomicrons Lipid-poor apoa-i Lipolysis
13 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
14 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
15 Lipidation of apoa-i Lipid-poor apoa-i Cell membrane ABCA-1 phospholipid, cholesterol Discoidal HDL
16 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
17 LCAT (lecithin:cholesterol acyltransferase) LCAT catalyses the reaction: phosphatidylcholine lysophosphatidylcholine unesterified cholesterol cholesteryl ester
18 LCAT The LCAT reaction is responsible for most of the cholesteryl esters circulating in plasma HDLs are the preferred substrates for LCAT LCAT is activated by apoa-i, apoa-iv, apoe LCAT NOT activated by apoa-ii
19 Role of LCAT in formation of spherical HDL Liver Intestine Free cholesterol transferred from cell membranes (including liver and intestine) apoa-i free cholesterol LCAT cholesteryl esters Discoidal HDL Spherical HDL
20 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
21 Role of TP in plasma cholesterol transport Liver LDL-R SR-B1 FC SR-B1 TP VLDL/LDL Bile HDL LCAT FC Extrahepatic Tissues (including the artery wall Free Cholesterol
22 Shuttle mechanism HDL TP TP TRL TG TG TG TG TG TP TG TP TG LDL Barter et al; Biochem J. 1982; 208:1. Swenson et al. J. Biol. Chem. 1988; 263:5150. Tall. J. Lipid Res.1993; 34:1255.
23 TP plays a major role in remodelling of HDL, especially when acting in the presence of hepatic lipase
24 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
25 HEPATIC LIPASE Hepatic lipase catalyses the hydrolysis of triglyceride and phospholipids in HDL Remodelling of HDL by hepatic lipase is most dramatic when linked to activity of TP
26 Role of TP and hepatic lipase in the remodelling of HDL HDL TGR-LP TG TP TG HDL TG Lipid-free/poor apoa-i TG HL FFA TG Excretion through kidney Small, dense HDL Rye et al Atherosclerosis, 1999,145:227 Rye et al Arterioscler Thromb Vasc Biol, 2004, 24: 421.
27 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
28 PLTP (phospholipid transfer protein) PLTP catalyses the transfer of phospholipids between plasma lipoproteins PLTP also remodels HDL
29 Remodelling of AI-HDL by PLTP PLTP PLTP PLTP lipid-poor apoa-i
30 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1
31 SRB1 (scavenger receptor type B1) SRB1 promotes the selective hepatic uptake of HDL cholesteryl esters SRB1 thus also remodels HDL
32 Remodelling of AI-HDL by SRB1 Liver Lipid-poor apoa-i SRB1 TG Larger HDL TG Smaller HDL
33 Apolipoprotein-specific HDL apoa-i apoa-i TG TG apoa-ii Spherical AI-HDL Spherical AI/AII-HDL
34 Origin of AII-HDL Secretion LIVER Lipid-poor apoa-ii phospholipids from cell membranes Discoidal AII-HDL
35 LCAT-mediated formation of spherical AI/AII-HDL Discoidal AI-HDL LCAT Spherical AI-HDL LCAT Fusion Spherical AI/AII-HDL TG LIVER Discoidal AII-HDL
36 Remodelling of HDL generates lipid-poor apoa-i
37 Remodelling of HDL generates lipid-poor apoa-i TG TP HL PLTP SRB1 TG Lipid-poor apoa-i
38 Fate of lipid-poor apoa-i Lipid-poor apoa-i Acquire PL from cells (via ABCA1) to form discoidal HDL Discoidal AI-HDL Incorporation into spherical AI-HDL Excretion through kidney Small, spherical AI-HDL LCAT Large, spherical AI-HDL
39 Cycling of apoa-i between HDL and a HDL TP HL PLTP SRB1 TG lipid-poor pool Lipid-poor apoa-i Excretion through kidney Discoidal HDL TG UC LCAT TG
40 Functions of HDL
41 Role of HDL in promoting efflux of cholesterol from cells
42 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i ABCA1 FC,PL
43 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i ABCA1 FC,PL Discoidal HDL
44 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL ABCA1 ABCA1 SR-B1 FC,PL FC
45 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT ABCA1 ABCA1 SR-B1 FC,PL FC Small spherical HDL
46 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT ABCA1 ABCA1 SR-B1 FC,PL FC Small spherical HDL Diffusion SR-B1 ABCG1 FC
47 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT Small spherical HDL LCAT ABCA1 ABCA1 SR-B1 Diffusion SR-B1 ABCG1 FC,PL FC FC Larger spherical HDL
48 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT Small spherical HDL LCAT ABCA1 ABCA1 SR-B1 Diffusion SR-B1 ABCG1 FC,PL FC FC Larger spherical HDL Diffusion SR-B1 ABCG1 FC
49 Protective properties of HDLs Promote cholesterol efflux from macrophages Anti-oxidant properties Anti-thrombotic properties Anti-inflammatory properties Improve endothelial function Promote endothelial repair Improve glycemic control Other
50 Conclusions The concentration of HDL-C correlates inversely with CV risk
51 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect
52 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment
53 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition
54 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition HDL particles are extensively remodelled in plasma by a variety of proteins and enzymes
55 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition HDL particles are extensively remodelled in plasma by a variety of proteins and enzymes Deficiencies of these remodelling factors result in major changes to HDL particles
56 Unanswered questions Q. Which HDL subpopulations (if any) protect against CV disease? Answer: We do not know Q. Which (if any) of the known HDL functions protect against CV disease? Answer: We do not know Answers to these questions require much more research
Lipid/Lipoprotein Structure and Metabolism (Overview)
Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures
More informationLipoproteins Metabolism
Lipoproteins Metabolism LEARNING OBJECTIVES By the end of this Lecture, the student should be able to describe: What are Lipoproteins? Describe Lipoprotein Particles. Composition of Lipoproteins. The chemical
More informationLipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry
Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Learning Objectives 1. Define lipoproteins and explain the rationale of their formation in blood. 2. List different
More informationANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism
ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism I. Chylomicrons (exogenous pathway) A. 83% triacylglycerol, 2% protein, 8% cholesterol plus cholesterol esters, 7% phospholipid (esp. phosphatidylcholine)
More informationChapter VIII: Dr. Sameh Sarray Hlaoui
Chapter VIII: Dr. Sameh Sarray Hlaoui Lipoproteins a Lipids are insoluble in plasma. In order to be transported they are combined with specific proteins to form lipoproteins: Clusters of proteins and lipids.
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationPathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
More informationLipids digestion and absorption, Biochemistry II
Lipids digestion and absorption, blood plasma lipids, lipoproteins Biochemistry II Lecture 1 2008 (J.S.) Triacylglycerols (as well as free fatty acids and both free and esterified cholesterol) are very
More informationCETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia
CETP inhibition: pros and cons Philip Barter The Heart Research Institute Sydney, Australia Philip Barter Disclosures Received honorariums for lectures, consultancies or membership of advisory boards from:
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationUnit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins
Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins - Cholesterol: It is a sterol which is found in all eukaryotic cells and contains an oxygen (as a hydroxyl group OH) on Carbon number
More informationGlossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein
More informationLIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE
LIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE Sebastiano Calandra Dipartimento di Scienze Biomediche Università di Modena e Reggio Emilia Incidence Rate/1000 200-150 - 100-50 - Women 0 Men
More informationAcetyl CoA HMG CoA Mevalonate (C6) Dimethylallyl Pyrophosphate isopentenyl Pyrophosphate (C5) Geranyl Pyrophosphate (C10) FarnesylPyrophosphate (C15) Squalene (C30) Lanosterol (C30) 7 Dehydrocholesterol
More informationNature Genetics: doi: /ng.3561
Supplementary Figure 1 Pedigrees of families with APOB p.gln725* mutation and APOB p.gly1829glufs8 mutation (a,b) Pedigrees of families with APOB p.gln725* mutation. (c) Pedigree of family with APOB p.gly1829glufs8
More informationHDL : A Treatment Target? ESC Paris M. John Chapman Ph.D., D.Sc., FESC. President, European Atherosclerosis Society
ESC Paris 2011 HDL : A Treatment Target? M. John Chapman Ph.D., D.Sc., FESC Director, Dyslipidemia and Atherosclerosis Research Unit, INSERM, University Pierre and Marie Curie, Hôpital de la Pitié-Salpetriere,
More informationMetabolism and Atherogenic Properties of LDL
Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal
More informationCholesterol Metabolism
Cholesterol Metabolism Lippincott s Illustrated Review Chapter 18 Steroid Nucleus 1 2 Cholesterol was isolated from gall bladder stones in 1774 3 Sources and Elimination of Cholesterol Synthesis: 1000
More informationPlasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam
Biochemistry Department Plasma lipoproteins & atherosclerosis by Prof.Dr. Maha M. Sallam 1 1. Recognize structures,types and role of lipoproteins in blood (Chylomicrons, VLDL, LDL and HDL). 2. Explain
More informationRegulating Hepatic Cellular Cholesterol
Under circumstances of cholesterol deficiency, Sterol Regulatory Element Binding Proteins (SREBPs) via binding to DNA nuclear response elements set off genomic production of proteins and enzymes that induce
More informationHugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors
Atherosclerosis Supplements 3 (2002) 39/47 www.elsevier.com/locate/atherosclerosis Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors P.J. Barter Hanson Institute, Adelaide,
More informationSummary and concluding remarks
Summary and concluding remarks This thesis is focused on the role and interaction of different cholesterol and phospholipid transporters. Cholesterol homeostasis is accomplished via a tightly regulated
More informationNiacin Metabolism: Effects on Cholesterol
Niacin Metabolism: Effects on Cholesterol By Julianne R. Edwards For Dr. William R. Proulx, PhD, RD Associate Professor of Nutrition and Dietetics In partial fulfillments for the requirements of NUTR342
More information2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries
Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global
More informationPPAR history of research
PPAR Rubens, 1640 PPAR history of research number of publications 3000 2000 1000 0 till now: : 16 296 publications 1985 1990 1995 2000 2005 year liver, brown adipocytes, kidney, heart, skeletal muscles,
More informationLipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel
Lipid Metabolism Department of Biochemistry and Molecular Biology II Medical Center Hamburg-ppendorf 1 Lipids. visceral fat. nutritional lipids 0 1.5 3 4.5 9 h. serum lipids. lipid accumulation in the
More informationChapter (5) Etiology of Low HDL- Cholesterol
Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the
More informationLipoprotein Pathophysiology. Lipoprotein Pathophysiology
Lipoprotein Pathophysiology Genetic Dyslipidemia Thomas A. Hughes, M.D. Professor of Medicine Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health Science Center GW is a 47
More informationCholesterol and its transport. Alice Skoumalová
Cholesterol and its transport Alice Skoumalová 27 carbons Cholesterol - structure Cholesterol importance A stabilizing component of cell membranes A precursor of bile salts A precursor of steroid hormones
More informationMechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes
Atherosclerosis 137 Suppl. (1998) S13 S17 Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes Michael C. Phillips *, Kristin L. Gillotte, M. Page Haynes, William
More informationCholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia
Cholesterol metabolism Function Biosynthesis Transport in the organism Hypercholesterolemia - component of all cell membranes - precursor of bile acids steroid hormones vitamin D Cholesterol Sources: dietary
More informationThere are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?
There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? Michael Davidson M.D. FACC, Diplomate of the American Board of Lipidology Professor,
More information5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT
5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT Prof. Victor Blaton, Ph.D. Department of Clinical Chemistry, Hospital AZ Sint-Jan
More informationLipid metabolism in familial hypercholesterolemia
Lipid metabolism in familial hypercholesterolemia Khalid Al-Rasadi, BSc, MD, FRCPC Head of Biochemistry Department, SQU Head of Lipid and LDL-Apheresis Unit, SQUH President of Oman society of Lipid & Atherosclerosis
More informationCHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL
CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL You will notice that the endogenous pathway is very similar to the exogenous pathway What is the average daily amount of triacylglycerol
More informationSTRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS. R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty
STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty STRUCTURE OF LIPIDS AND LIPOPROTEINS DEFINTITION: Compounds Insoluble in water But
More informationDisclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017
Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital
More informationMendelian disorders refer to diseases caused by mutations. Review. Mendelian Disorders of High-Density Lipoprotein Metabolism
Review This Review is part of a thematic series on High-Density Lipoprotein, which includes the following articles: Mendelian Disorders of HDL Metabolism Regulation of High-Density Lipoprotein Metabolism
More informationN-3 Fatty Acids Non-HDL-Cand LDL-C Thomas Dayspring MD, FACP
Omega or N-3 Fatty Acids (FA) significantly reduce TG synthesis and significantly deplete the TG content of VLDL particles indicated by significantly reduced V. FA are the substrate for TG synthesis. N3-FA
More informationThe role of HDL-cholesterol in preventing atherosclerotic disease
European Heart Journal Supplements (2005) 7 (Supplement F), F4 F8 doi:10.1093/eurheartj/sui036 The role of HDL-cholesterol in preventing atherosclerotic disease Philip Barter* The Heart Research Institute,
More informationThe New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk
The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing
More informationHDL and Its Galaxy of Proteins: What Do they Do? Jay Heinecke, University of Washington
HDL and Its Galaxy of Proteins: What Do they Do? Jay Heinecke, University of Washington Disclosures NIH AHA Insilicos Consultant Merck Research Support GSK Research Support Pfizer Research Support Corcept
More informationESC Congress 2011 Wednesday August 31st 2011
ESC Congress 211 Wednesday August 31st 211 stimulates endothelial CAT-1 expression and L-arginine uptake: a novel mechanism leading to endothelial-protective effects of that is profoundly impaired in patients
More informationContributions in Medicine: Will CETP Inhibition Contribute Toward Reduction of Cardiovascular Risk?
Contributions in Medicine: Will TP Inhibition Contribute Toward Reduction of Cardiovascular Risk? Activity presentations are considered intellectual property. These slides may not be published or posted
More informationSupplemental Material. Results
Supplemental Material Results Fractionation of mouse plasma by high-resolution SEC. APOA1 eluted as a single major peak in fractions 16 of plasma (the apparent size of mature, lipidated HDL) when it was
More informationHypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002
Hypertriglyceridemia Ara Metjian, M.D. Resident s Report 20 December 2002 Review of Lipids Chylomicrons (CM): Dietary lipids absorbed through the GI tract are assembled intracellularly into CM. Very Low
More informationDipartimento di Scienze Cliniche Luigi Sacco SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE BIOCHIMICHE, NUTRIZIONALI E METABOLICHE
Dipartimento di Scienze Cliniche Luigi Sacco SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE BIOCHIMICHE, NUTRIZIONALI E METABOLICHE DOTTORATO DI RICERCA IN NUTRIZIONE SPERIMENTALE E CLINICA CICLO XXIII TESI
More informationLipid Metabolism in Familial Hypercholesterolemia
Lipid Metabolism in Familial Hypercholesterolemia Khalid Al-Rasadi, BSc, MD, FRCPC Head of Biochemistry Department, SQU Head of Lipid and LDL-Apheresis Unit, SQUH President of Oman society of Lipid & Atherosclerosis
More informationProf. John Chapman, MD, PhD, DSc
Prof. John Chapman, MD, PhD, DSc Director of the Dyslipidemia and Atherosclerosis Research Unit of the National Institute for Health and Medical Research (INSERM) at the Pitié-Salpétrière Hospital in Paris
More informationRole of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD
Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal
More informationTC =96; HDL-C = 21; Non-HDL-C = 75; LDL-C: less than 10 TG: 357; VLDL-C = 71; TG/HDL-C: 17 TC/HDL-C = 4.5
LIPID CASE 269 He said - she said?? I want to have some fun with this issue's case discussion. It was sent to me by a respected lipidologist who shared a case first seen by his nurse practitioner. They
More informationPart 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD
Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,
More informationFormation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I Kerry-Anne Rye, Philip J. Barter Abstract The preferred extracellular acceptor of cell phospholipids and unesterified cholesterol
More informationChapter 1 GENERAL INTRODUCTION. 1.1 Lipoproteins and Lipid Metabolism
GENERAL INTRODUCTION Contents 1.1 Lipoproteins and lipid metabolism 1.2 Atherosclerosis 1.3 HDL and atherosclerosis 1.4 ABCA-transporters 1.5 Lipid transfer proteins: CETP and PLTP 1.6 Macrophage RCT pathway:
More informationPlacental Transport in Pathologic Pregnancies
Note: for non-commercial purposes only Placental Transport in Pathologic Pregnancies Gernot Desoye Clinic of Obstetrics and Gynaecology Medical University, Graz Most Common Pregnancy Pathologies Diabetes
More informationLipids, lipoproteins and cardiovascular disease
Lipids, lipoproteins and cardiovascular disease Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Cardiovascular disease Plasma enzymes
More informationZuhier Awan, MD, PhD, FRCPC
Metabolism, Atherogenic Properties and Agents to Reduce Triglyceride-Rich Lipoproteins (TRL) The Fifth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 8-11, 2019 Zuhier
More informationreview Cell cholesterol efflux: integration of old and new observations provides new insights
Cell cholesterol efflux: integration of old and new observations provides new insights review George H. Rothblat, 1, * Margarita de la Llera-Moya,* Veronique Atger, Ginny Kellner-Weibel,* David L. Williams,
More informationHypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC
Hypertriglyceridemia: Why, When, and How to Treat Gregory Cohn, MD, FNLA, FASPC DISCLOSURES Consultant to Akcea Therapeutics (in the past 12 months). OUTLINE I. Lipoproteins II. Non-HDL-C III. Causes and
More informationCholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss
Cholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss Charlotte P.J. Talbot The studies presented in this thesis were performed within NUTRIM School of
More informationMoh Tarek + Suhayb. Tamara Al-Azzeh + Asmaa Aljeelani ... Faisal
28 Moh Tarek + Suhayb Tamara Al-Azzeh + Asmaa Aljeelani... Faisal Digestion of dietary lipids Lipid digestion and absorption are complex processes. They involve soluble enzymes, substrates with different
More informationA Study of Omega-3 Fatty Acid. Therapy in Patients with. Nephrotic Syndrome
A Study of Omega-3 Fatty Acid Therapy in Patients with Nephrotic Syndrome Dr Samira Siddiqui Renal Unit Glasgow Royal Infirmary Thesis for the degree of MD, Faculty of Medicine, University of Glasgow Submitted
More informationHigh density lipoprotein metabolism
High density lipoprotein metabolism Shlomo Eieenberg Lipid Research Laboratory, Department of Medicine B, Hadassah University Hospital, Jerusalem, Israel 1. INTRODUCTION Interest in high density lipoproteins
More informationHyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi
Hyperlipidemia Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Outline The story of lipids Definition of hyperlipidemia Classification of hyperlipidemia Causes of hyperlipidemia
More informationCHAPTER 1. General Introduction
CHAPTER 1 General Introduction General Introduction Contents 1. Lipoproteins and lipid metabolism 1. Exogenous pathway 2. Endogenous pathway 3. Reverse cholesterol pathway 2. Atherosclerosis 1. Pathogenesis
More information13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
More informationReverse Cholesterol Transport and Atherosclerosis
JCR2014 (2014.12.13@Novotel, Busan, South Korea) Reverse Cholesterol Transport and Atherosclerosis Shizuya Yamashita, MD, PhD, FAHA, FJCC Department of Community Medicine Department ofcardiovascular Medicine
More informationRelevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins
1070 Biochemical Society Transactions (2003) Volume 31, part 5 Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins A. Zambon 1,S.Bertocco, N. Vitturi, V. Polentarutti, D.
More informationPLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL
PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL Lipids are characterized by low polarity and limited solubility in water. Their plasma concentration is about 500-600
More informationANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD
ANTIHYPERLIPIDEMIA Darmawan,dr.,M.Kes,Sp.PD Plasma lipids consist mostly of lipoproteins Spherical complexes of lipids and specific proteins (apolipoproteins). The clinically important lipoproteins, listed
More informationMETABOLISM of ADIPOSE TISSUE
METABOLISM of ADIPOSE TISSUE 2. LF UK Prof. Rudolf Poledne, PhD. TYPES OF ADIPOSE TISSUE brown adipose tissue subcutaneous adipose tissue visceral adipose tissue ADIPOSE TISSUE FUNCTIONS: thermal isolation
More informationLipidaholics Anonymous Case 2012;13:(1);284 Explaining the unexplainable LDL- P
1 Lipidaholics Anonymous Case 2012;13:(1);284 Explaining the unexplainable LDL- P A respected cardiologist contacted me about the following dilemma. He has a primary prevention case which is a woman with
More informationSuppl. Table 1: CV of pooled lipoprotein fractions analysed by ESI-MS/MS
Supplement VLDL LDL HDL PC 3.3 1.77 1.3 LPC 4.82 2.5.35 SM 3.1 4.6 1.92 CER 2.17 6.3 4.15 PE 3.18 1.93 2.79 PE-pl 13.18 1.9 2.32 CE 2.9.65.4 FC.36 3.5 2.54 Suppl. Table 1: CV of pooled lipoprotein fractions
More informationReduction in Serum Lecithin:Cholesterol Acyltransferase Activity Prior to the Occurrence of Ketosis and Milk Fever in Cows
FULL PAPER Biochemistry Reduction in Serum Lecithin:Cholesterol Acyltransferase Activity Prior to the Occurrence of Ketosis and Milk Fever in Cows Hisami NAKAGAWA-UETA 1) and Norio KATOH 2) * 1) Ishikawa
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationINTERNATIONAL JOURNAL OF BIOASSAYS ISSN: X CODEN: IJBNHY OPEN ACCESS
ORIGINAL RESEARCH ARTICLE A CLINICAL STUDY OF DYSLIPIDEMIA IN PATIENTS OF CHRONIC KIDNEY DISEASE Gourav Garg 1, Sumit Pal Singh Chawla 2 * and Sarabjot Kaur 2 1 Department of Medicine, Government Medical
More informationCellular control of cholesterol. Peter Takizawa Department of Cell Biology
Cellular control of cholesterol Peter Takizawa Department of Cell Biology Brief overview of cholesterol s biological role Regulation of cholesterol synthesis Dietary and cellular uptake of cholesterol
More informationCholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins
Review Article Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins A. R. Tall From the Division of Molecular Medicine, Department
More informationThematic review series: The Immune System and Atherogenesis
thematic review Thematic review series: The Immune System and Atherogenesis Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? Alan Chait, 1 Chang Yeop Han, John
More information*Address Correspondence to Päivi Pajukanta, MD, PhD, Associate Professor, Department of
Genetic Causes of High and Low Serum HDL-cholesterol Daphna Weissglas-Volkov 1 and Päivi Pajukanta 1 1 Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, United
More informationThe Role of Apolipoprotein CIII in Coronary Artery Disease. Disclosures
Miami Cardiac & Vascular Institute Cardiovascular Disease Prevention 15th Annual Symposium February 16, 2017 Nobu Eden Roc Hotel, Miami Beach, Florida. The Role of Apolipoprotein CIII in Coronary Artery
More informationAnti Hyperlipidemic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Anti Hyperlipidemic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Lipoproteins Macromolecular complexes in the blood that transport lipids Apolipoproteins
More informationLIPIDS OF BLOODSTREAM
HEC No. 1428 ISSN No. 1681-5491 CARDIOLOGY MEDICAL CHANNEL Vol. 15, No. 2 APRIL - JUNE 2009 EDITORIAL LIPIDS OF BLOODSTREAM 1. ZAFAR ALAM MAHMOOD 2. SYED WASEEMUDDIN AHMED 3. MOHAMMAD SUALEH 4. SAAD BIN
More informationLIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI
LIPID METABOLISM Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI Lipid metabolism is concerned mainly with fatty acids cholesterol Source of fatty acids from dietary fat de novo
More informationIntroduction REVIEW. M. John Chapman*, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush. Keywords
European Heart Journal (2010) 31, 149 164 doi:10.1093/eurheartj/ehp399 REVIEW Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin,
More informationMetabolism and Protective Properties of HDL
Metabolism and Protective Properties of HDL A riddle wrapped in a mystery inside an enigma Jacques Genest MD Cardiovascular Research Laboratories McGill University Health Center Disclosure J. Genest MD
More informationLipids Board Review. Ira Goldberg, MD New York University School of Medicine. Which of the following is the best initial therapy choice?
Lipids Board Review Ira Goldberg, MD New York University School of Medicine 1. A 22 year old male college student is referred for severe hypertriglyceridemia ( 1500 mg/dl [ 17.0 mmol/l]). He has a history
More informationCHM333 LECTURE 34: 11/30 12/2/09 FALL 2009 Professor Christine Hrycyna
Lipid Metabolism β-oxidation FA Acetyl-CoA Triacylglycerols (TAGs) and glycogen are the two major forms of stored energy in vertebrates Glycogen can supply ATP for muscle contraction for less than an hour
More informationThe Addition of Ezetimibe to Statin therapy in. Patients with Homozygous Familial. Hypercholesterolaemia
The Addition of Ezetimibe to Statin therapy in Patients with Homozygous Familial Hypercholesterolaemia Submitted in fulfilment with the requirements for the degree Master in Medicine (MMed) Dr Adriano
More informationGlossary For TheFatNurse s For All Ages Series Apolipoprotein B (APOB or ApoB) are the primary apolipoproteins of chylomicrons and low-density lipoproteins (LDL - known commonly by the misnomer "bad cholesterol"
More informationBy: Dr Hadi Mozafari 1
Biological lipids are a chemically diverse group of compounds, the common and defining feature of which is their insolubility in water. By: Dr Hadi Mozafari 1 Fats and oils are the principal stored forms
More informationCentral role of apociii
University of Copenhagen & Copenhagen University Hospital Central role of apociii Anne Tybjærg-Hansen MD DMSc Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen,
More informationIntroduction Hyperlipidemia hyperlipoproteinemia Primary hyperlipidemia (Familial) Secondary hyperlipidemia (Acquired)
Introduction Hyperlipidemia, or hyperlipoproteinemia, is the condition of abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. Hyperlipidemias are divided in primary and secondary
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationPlasma lipid transfer proteins
Plasma lipid transfer proteins Alan R. Tall Department of Medicine, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032 Introduction The composition of
More informationMetabolic defects underlying dyslipidemia in abdominal obesity
Metabolic defects underlying dyslipidemia in abdominal obesity Professor Marja-Riitta Taskinen Department of Medicine, Division of Cardiology Helsinki University Hospital, Finland Disclosures: Honorariums/
More informationAlow level of HDL cholesterol is an important cardiovascular
High Density Lipoproteins and Arteriosclerosis Role of Cholesterol Efflux and Reverse Cholesterol Transport Arnold von Eckardstein, Jerzy-Roch Nofer, Gerd Assmann Abstract High density lipoprotein (HDL)
More informationThematic Review Series: Genetics of Human Lipid Diseases. Genetic causes of high and low serum HDL-cholesterol
thematic review Thematic Review Series: Genetics of Human Lipid Diseases Genetic causes of high and low serum HDL-cholesterol Daphna Weissglas-Volkov and Päivi Pajukanta 1 Department of Human Genetics,
More information